Libo Xu

578 total citations
28 papers, 394 citations indexed

About

Libo Xu is a scholar working on Molecular Biology, Organic Chemistry and Epidemiology. According to data from OpenAlex, Libo Xu has authored 28 papers receiving a total of 394 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Organic Chemistry and 5 papers in Epidemiology. Recurrent topics in Libo Xu's work include Pregnancy and preeclampsia studies (4 papers), Cancer therapeutics and mechanisms (4 papers) and Metabolism, Diabetes, and Cancer (3 papers). Libo Xu is often cited by papers focused on Pregnancy and preeclampsia studies (4 papers), Cancer therapeutics and mechanisms (4 papers) and Metabolism, Diabetes, and Cancer (3 papers). Libo Xu collaborates with scholars based in China and United States. Libo Xu's co-authors include David E. Moller, A. Brian Jones, Peter T. Meinke, Deborah Szalkowski, S.-E. W. Huskey, Victor Ding, Kun Liu, James V. Heck, Bei B. Zhang and Gloria Y. Kwei and has published in prestigious journals such as Journal of Biological Chemistry, ACS Applied Materials & Interfaces and Journal of Medicinal Chemistry.

In The Last Decade

Libo Xu

26 papers receiving 379 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Libo Xu China 11 204 83 71 43 41 28 394
Lina A. Dahabiyeh Jordan 15 288 1.4× 73 0.9× 47 0.7× 39 0.9× 42 1.0× 56 589
Philippe Chabert France 16 243 1.2× 88 1.1× 21 0.3× 29 0.7× 24 0.6× 38 649
Sarah Tomas‐Hernández Spain 7 234 1.1× 56 0.7× 64 0.9× 37 0.9× 39 1.0× 10 418
Shien Zou China 14 155 0.8× 22 0.3× 33 0.5× 29 0.7× 38 0.9× 30 481
Arnab Sarkar India 12 159 0.8× 42 0.5× 16 0.2× 22 0.5× 24 0.6× 37 400
Yunyun Zhu China 16 165 0.8× 77 0.9× 44 0.6× 45 1.0× 18 0.4× 38 517
Xiaorong Ran China 7 184 0.9× 50 0.6× 17 0.2× 53 1.2× 10 0.2× 8 428
Christopher P. Laudeman United States 10 188 0.9× 64 0.8× 38 0.5× 94 2.2× 34 0.8× 15 409
Lauren B. Arendse South Africa 9 150 0.7× 23 0.3× 32 0.5× 19 0.4× 63 1.5× 11 417
Munichandra Babu Tirumalasetty India 11 138 0.7× 179 2.2× 48 0.7× 30 0.7× 38 0.9× 23 424

Countries citing papers authored by Libo Xu

Since Specialization
Citations

This map shows the geographic impact of Libo Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Libo Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Libo Xu more than expected).

Fields of papers citing papers by Libo Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Libo Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Libo Xu. The network helps show where Libo Xu may publish in the future.

Co-authorship network of co-authors of Libo Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Libo Xu. A scholar is included among the top collaborators of Libo Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Libo Xu. Libo Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Libo, Zhenhao Wang, & Qingsong Li. (2025). Global trends and projections of Parkinson’s disease incidence: a 30-year analysis using GBD 2021 data. Journal of Neurology. 272(4). 286–286. 8 indexed citations
2.
Xu, Libo, Zhenhao Wang, Mao Li, & Qingsong Li. (2025). Global incidence trends and projections of Alzheimer disease and other dementias: an age-period-cohort analysis 2021. Journal of Global Health. 15. 4156–4156. 2 indexed citations
3.
Xiong, Jun, et al.. (2025). Dynamic trend analysis of global psoriasis burden from 1990 to 2021: a study of gender, age, and regional differences based on GBD 2021 data. Frontiers in Public Health. 13. 1518681–1518681. 4 indexed citations
4.
Xu, Libo, et al.. (2025). Triglyceride glucose-body mass index and the risk of gestational diabetes mellitus: a prospective pregnancy nutrition cohort study. Diabetes Research and Clinical Practice. 229. 112901–112901.
5.
Chen, Lumin, Yanling Chen, Xian Han, et al.. (2024). Risk factors associated with wheezing in severe pediatric community-acquired pneumonia: a retrospective study. Minerva Pediatrics. 76(3). 1 indexed citations
7.
Xu, Libo, et al.. (2023). Maternal body mass index and risk of fetal overgrowth in women with gestational diabetes Mellitus in Southeast China: a retrospective cohort study. Diabetology & Metabolic Syndrome. 15(1). 121–121. 2 indexed citations
8.
Sun, Xiaofan, Min Zhao, Dong Li, et al.. (2023). Enhanced Electrocaloric Effect of Lead Scandium Tantalate by Zirconium Doping. ACS Applied Materials & Interfaces. 15(44). 51252–51261. 4 indexed citations
9.
Singh, Sheo B., Lynn Miesel, Susanne Krämer, et al.. (2022). Nocathiacin, Thiazomycin, and Polar Analogs Are Highly Effective Agents against Toxigenic Clostridioides difficile. Journal of Natural Products. 85(4). 1141–1146. 3 indexed citations
10.
Ma, Mei, Mei Zhu, Li Li, et al.. (2020). Use of complete blood count for predicting preterm birth in asymptomatic pregnant women: A propensity score‐matched analysis. Journal of Clinical Laboratory Analysis. 34(8). e23313–e23313. 22 indexed citations
11.
Lin, Juan, Xiaodan Mao, Libo Xu, et al.. (2020). Gestational weight gain charts for twin pregnancies in Southeast China. BMC Pregnancy and Childbirth. 20(1). 127–127. 6 indexed citations
12.
Singh, Sheo B., Libo Xu, Peter T. Meinke, et al.. (2017). Thiazomycin, nocathiacin and analogs show strong activity against clinical strains of drug-resistant Mycobacterium tuberculosis. The Journal of Antibiotics. 70(5). 671–674. 8 indexed citations
13.
Wang, Yongshan, et al.. (2017). Development of CDV-specific monoclonal antibodies for differentiation of variable epitopes of nucleocapsid protein. Veterinary Microbiology. 211. 84–91. 14 indexed citations
14.
Xu, Libo, James F. Dropinski, Peter T. Meinke, et al.. (2012). Synthesis and antibacterial activity of novel water-soluble nocathiacin analogs. Bioorganic & Medicinal Chemistry Letters. 23(1). 366–369. 19 indexed citations
15.
He, Feng, et al.. (2009). Study on the complex hepatitis C virus antigen with multi-genotype E1 epitopes. Zhonghua weishengwuxue he mianyixue zazhi. 29(1). 46–52. 2 indexed citations
17.
Xu, Libo, James F. Dropinski, Peter T. Meinke, et al.. (2009). Nocathiacin analogs: Synthesis and antibacterial activity of novel water-soluble amides. Bioorganic & Medicinal Chemistry Letters. 19(13). 3531–3535. 28 indexed citations
18.
Xu, Libo, Timothy F. Walseth, & James T. Slama. (2005). Cyclic ADP-Ribose Analogues Containing the Methylenebisphosphonate Linkage:  Effect of Pyrophosphate Modifications on Ca2+ Release Activity. Journal of Medicinal Chemistry. 48(12). 4177–4181. 16 indexed citations
19.
Qureshi, Sajjad A., Victor Ding, Zhihua Li, et al.. (2000). Activation of Insulin Signal Transduction Pathway and Anti-diabetic Activity of Small Molecule Insulin Receptor Activators. Journal of Biological Chemistry. 275(47). 36590–36595. 56 indexed citations
20.
Liu, Kun & Libo Xu. (2000). Synthesis of 5,6-dihydro-4-hydroxy-2-pyrones via formal cycloaddition reactions. Tetrahedron Letters. 41(18). 3299–3302. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026